PATENT CLAIM ANALYSIS

Application Number: 15913606
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
Compositions and methods are described for delivery of drugs to desired tissues via soluble quantum dots.

Claim (Index 9):
The light responsive quantum dot drug delivery system of  claim 8 , wherein the capping ligand is selected from the group consisting of: thiol, carboxyl, amine, phosphine, phosphine oxide, phosphonic acid, phosphinic acid, imidazole, OH, thio ether, and calixarene groups.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 90.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15559577', '11919681', '11116454', '13455674', '14615243']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7420908257980178
- 35 USC 102 Novelty (BERT): 0.4807908478049897
- Combined Prediction Score: 0.715960827998715
- Mean Citation Score: 184.43406
- Max Citation Score: 191.37927
- Similarity Product: 140.908106128453

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test